PharmaShots Connects Brands & Decision-Makers with Custom Media Solutions PharmaShots Provides Curated News & Insights for the Biopharma & Healthcare Industry PharmaShots is Empowering Decision Makers with Actionable Insights Amplify Your Brand with PharmaShots’ Expert Content Creation & Marketing Solutions PharmaShots Enables Brands to Strategically Connect with Their Target Audiences Deliver Your News to the Right Audience with PharmaShots Newswire SPOTLIGHT INTERVIEW SPOTLIGHTCXO Talks: Tim O’Connell from Emtelligent in a Striking Conversation with PharmaShots SPOTLIGHTCXO Talks: Colin Banas from DrFirst in an Illuminating Conversation with PharmaShots SPOTLIGHTReuters Pharma 2025: Post-Conference Talks Featuring Barbara Albientz SPOTLIGHTReuters Pharma 2025: Post-Conference Talks Featuring Michael Bierl SPOTLIGHTReuters Pharma 2025: Post Conference Talks Featuring Jayasree K. Iyer SPOTLIGHTReuters Pharma 2025: Post-Conference Talks Featuring Hector De La Riva SPOTLIGHTCXO Talks: Ali Jannati from Linus Health in a Stimulating Dialogue Exchange with PharmaShots SPOTLIGHTReuters Pharma 2025: Pre-Conference Talks Featuring Mike Ryan EXCLUSIVE INTERVIEW EXCLUSIVEExclusive: Dr. Mónica Domínguez from Smile Train in a Stimulating Conversation with PharmaShots on Why a Healthy Mouth is a Happy Mind EXCLUSIVEExclusive: Kenneth Sake from Blueprint Medicines in an Enlightening Conversation with PharmaShots EXCLUSIVEExclusive Coverage: Dr. Ikshit Sharma from AIMIL Pharmaceuticals in a Stimulating Dialogue Exchange with PharmaShots EXCLUSIVEAdvancing Care for Hematologic Malignancies: Chris Heery from Arcellx in a Stimulating Dialogue Exchange with PharmaShots EXCLUSIVEDecoding Approval: Moitreyee Chatterjee-Kishore from Astellas in an Exclusive Conversation with PharmaShots EXCLUSIVEAdvancing Urothelial Carcinoma Care: Ahsan Arozullah from Astellas Pharma in an Exclusive Interview with PharmaShots EXCLUSIVEExclusive: David Esposito in an Illuminating Discussion with PharmaShots EXCLUSIVEExclusive: GeoVax’s CEO David A. Dodd in an Engaging Conversation with PharmaShots LATEST NEWSStay up-to-date Regeneron and Sanofi Receive the US FDA’s Approval for Dupixent to Treat Bullous Pemphigoid 13 minutes ago ExCellThera Reports CHMP’s Positive Opinion for Zemcelpro to Treat Haematological Malignancies 2 hours ago Johnson & Johnson MedTech Reports the US Launch of VOLT Wrist and Proximal Humerus Plating Systems 3 hours ago ELIAS Animal Health Reports Interim Study Data of ELIAS Cancer Immunotherapy (ECI) in Canine Osteosarcoma 4 hours ago Merck and Daiichi Sankyo Report First Patient Dosing with Ifinatamab DXd in P-III (IDeate-Prostate01) Trial for mCRPC 22 hours ago Novartis Reports the Health Canada’s Approval of Kisqali (Ribociclib) for the Treatment of HR+/HER2- Early Breast Cancer 23 hours ago Read More Your Daily Dose of Biopharma News & Insights Delivered to Your Inbox. Join the PharmaShots Family of 20000+ subscribers Subscribe Now Youtube VideosStay up-to-dateMore Posts
Regeneron and Sanofi Receive the US FDA’s Approval for Dupixent to Treat Bullous Pemphigoid 13 minutes ago
ExCellThera Reports CHMP’s Positive Opinion for Zemcelpro to Treat Haematological Malignancies 2 hours ago
Johnson & Johnson MedTech Reports the US Launch of VOLT Wrist and Proximal Humerus Plating Systems 3 hours ago
ELIAS Animal Health Reports Interim Study Data of ELIAS Cancer Immunotherapy (ECI) in Canine Osteosarcoma 4 hours ago
Merck and Daiichi Sankyo Report First Patient Dosing with Ifinatamab DXd in P-III (IDeate-Prostate01) Trial for mCRPC 22 hours ago
Novartis Reports the Health Canada’s Approval of Kisqali (Ribociclib) for the Treatment of HR+/HER2- Early Breast Cancer 23 hours ago
